Table 2.
Demographic and clinics characteristics of patients with lipodystrophy compared with no lipodystrophy.
| Lipodystrophy group n = 34 |
No lipodystrophy group n = 29 |
|
|---|---|---|
| Age | 44.9 ± 8.9 | 40.8 ± 9.6 |
| Gender (male:female) | 18:15 | 16:14 |
| Body mass index (kg m−2) | 23.0 ± 4.5 | 23.1 ± 2.0 |
| Muscle mass | 49.2 ± 10.2 | 55.6 ± 11.8* |
| Body fat (%) | 27.6 ± 11.8 | 19.9 ± 7.3* |
| Waist | 81.4 ± 11.7 | 80.9 ± 6.9 |
| Hip | 95.82 ± 9.17 | 95.53 ± 4.74 |
| CD4+ (cell mm−3) | 490.4 ± 25.,6 | 597.6 ± 320.3 |
| Triglycerides (mg dL−1) | 197.3 ± 88.1 | 172.4 ± 118.2 |
| Total cholesterol (mg dL−1) | 217.8 ± 79.9 | 194.6± 35.2 |
| HDL cholesterol (mg dL−1) | 52.4 ± 22.8 | 44.2± 14.6 |
| Glucose (mg dL−1) | 90.2± 18.4 | 90.3± 10.5 |
| Metabolic syndrome (yes:no) | 19:15 | 8:21* |
| Peak VO2 (mL kg−1 min−1) | 31.4 ± 6.1 | 30.4 ± 7.6* |
| MET | 9.3 ± 1.8 | 8.7 ± 2.2* |
*
p < 0.05.